文献速递心外重症与机械循环支持

部分至全支撑微轴流泵升级对持久左心室辅助装置植入的影响

Impact of Partial- to Full-Support Escalation With Microaxial Flow Pumps Prior to Durable Left Ventricular Assist Device Implantation.
PubMed 文献 · Eur J Cardiothorac Surg · 2026-01-01

该多中心回顾性研究分析130例在微轴流泵(mAFP)支持下接受持久左心室辅助装置(dLVAD)植入的患者,其中38例升级至全支撑mAFP。升级组30天生存率与未升级组相似,但1年生存率更高,且部分支撑mAFP联合VA-ECLS的患者死亡风险较高,升级可能改善生存并促进VA-ECLS撤除。

要点

  • 部分支撑mAFP联合VA-ECLS患者死亡风险较高,HR 2.06。
  • 升级至全支撑mAFP与1年生存率提高相关,HR 0.41。
  • 升级组更易在dLVAD植入前撤除VA-ECLS。

核心结论

  • 在部分支撑mAFP联合VA-ECLS的患者中,升级至全支撑mAFP可能改善生存,应考虑用以促进VA-ECLS撤除。

研究设计与样本

  • 回顾性分析17个欧洲心脏中心2015年2月至2022年8月间130例在mAFP(伴或不伴VA-ECLS)后接受dLVAD植入的患者。

主要发现

  • 升级组中位支持时间显著更长:12天[9, 21] vs 7天[4, 11],P < .001。
  • 升级组更多患者在dLVAD植入前撤除VA-ECLS:10例(71.4%)vs 6例(11.3%),P < .001。
  • 30天生存率两组相似:89.5% vs 84.8%(IPTW加权OR 1.00 [95% CI, 0.46-2.22],P = .992)。
  • 估计1年生存率升级组更高:84.0% [95% CI, 73.0-96.6] vs 63.7% [95% CI, 54.3-74.6],HR 0.41 [95% CI, 0.17-0.99],P = .048。
  • 部分支撑mAFP联合VA-ECLS患者死亡风险高于所有其他患者:HR 2.06 [95% CI, 1.16-3.36],P = .013。

临床怎么用

  • 对部分支撑mAFP联合VA-ECLS的患者,可考虑升级至全支撑mAFP以促进VA-ECLS撤除并可能改善生存。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Microaxial flow pumps (mAFP) effectively bridge patients with cardiogenic shock to durable left ventricular assist device (dLVAD) implantation. The partial-support mAFPs provide only up to 3.5 L/min, which might be insufficient for an effective circulatory support and preconditioning for a dLVAD implantation. Alternatively, patients with refractory shock on partial support may benefit from an escalation to a full-support mAFP. METHODS: A retrospective analysis of 130 patients was performed across 17 European cardiac centres who underwent dLVAD implantation following mAFP with or without venoarterial extracorporeal life support (VA-ECLS) between February 2015 and August 2022. Ninety-two patients (70.8%) were bridged on partial-support mAFP, while 38 patients (29.2%) underwent an escalation to full-support mAFP. RESULTS: Median support duration was significantly longer in the escalation group (7 days [4, 11] vs 12 days [9, 21], P < .001). Patients in the escalation group were more likely to be weaned from VA-ECLS before dLVAD implantation, 10 (71.4%) vs 6 (11.3%), P < .001. Thirty-day survival was similar between the escalation and no-escalation groups, 89.5% vs 84.8% (IPTW-weighted OR, 1.00 [95% CI, 0.46-2.22], P = .992). Estimated 1-year survival was higher in the escalation group: 84.0% [95% CI, 73.0-96.6] vs 63.7% [95% CI, 54.3-74.6], HR 0.41 [95% CI, 0.17-0.99], P = .048. Patients with a combination of partial-support mAFP and VA-ECLS had a higher mortality risk than all other patients, HR 2.06 [95% CI, 1.16-3.36], P = .013. CONCLUSIONS: In patients with partial-support mAFP and concomitant VA-ECLS, an escalation to a full-support mAFP may translate to improved survival and should be considered to facilitate VA-ECLS weaning.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Lewin D, Nersesian G, Rojas SV, et al. Impact of Partial- to Full-Support Escalation With Microaxial Flow Pumps Prior to Durable Left Ventricular Assist Device Implantation. Eur J Cardiothorac Surg. 2026. PMID: 42087324. doi:10.1093/ejcts/ezag165

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。